FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 253 filers reported holding FATE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,121 | -100.0% | 309,359 | -0.6% | 0.02% | -57.4% |
| Q3 2022 | $6,977,000 | +45.4% | 311,331 | +60.8% | 0.05% | +54.3% |
| Q2 2022 | $4,798,000 | -31.5% | 193,637 | +7.2% | 0.04% | -14.6% |
| Q1 2022 | $7,003,000 | -32.9% | 180,620 | +4.0% | 0.04% | -24.1% |
| Q4 2021 | $10,434,000 | +24.0% | 173,704 | +22.4% | 0.05% | +17.4% |
| Q3 2021 | $8,413,000 | -31.7% | 141,951 | 0.0% | 0.05% | -39.5% |
| Q2 2021 | $12,320,000 | +561.3% | 141,951 | +528.1% | 0.08% | +533.3% |
| Q1 2021 | $1,863,000 | -9.3% | 22,600 | 0.0% | 0.01% | -14.3% |
| Q4 2020 | $2,055,000 | +576.0% | 22,600 | +197.4% | 0.01% | +600.0% |
| Q3 2020 | $304,000 | -62.9% | 7,600 | -68.2% | 0.00% | -71.4% |
| Q2 2020 | $820,000 | – | 23,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,073,190 | $26,599,000 | 26.59% |
| Polaris Venture Management Co. V, L.L.C. | 1,823,186 | $23,391,000 | 24.97% |
| Casdin Capital, LLC | 2,550,000 | $32,717,000 | 5.60% |
| Redmile Group, LLC | 10,359,666 | $132,915,000 | 5.34% |
| Aquilo Capital Management, LLC | 697,096 | $8,944,000 | 4.33% |
| Eversept Partners, LP | 165,000 | $2,116,950 | 1.15% |
| Artal Group S.A. | 2,150,000 | $27,585,000 | 1.02% |
| AlpInvest Partners B.V. | 26,925 | $345,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,654,865 | $21,232,000 | 0.85% |
| Lisanti Capital Growth, LLC | 142,760 | $1,832,000 | 0.74% |